000			02046 a2200565 4500
005			20250516013533.0
264		0	_c20110120
008			201101s 0 0 eng d
022			_a1532-6535
024	7		_a10.1038/clpt.2010.250 _2doi
040			_aNLM _beng _cNLM
100	1		_aJi, Y
245	0	0	_aGlycine and a glycine dehydrogenase (GLDC) SNP as citalopram/escitalopram response biomarkers in depression: pharmacometabolomics-informed pharmacogenomics. _h[electronic resource]
260			_bClinical pharmacology and therapeutics _cJan 2011
300			_a97-104 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Validation Study
650	0	4	_aBiomarkers, Pharmacological _xblood
650	0	4	_aCell Line
650	0	4	_aChromosomes, Human, Pair 9 _xgenetics
650	0	4	_aCitalopram _xtherapeutic use
650	0	4	_aDNA-Binding Proteins _xmetabolism
650	0	4	_aDepressive Disorder, Major _xblood
650	0	4	_aDrug Monitoring _xmethods
650	0	4	_aFemale
650	0	4	_aGenetic Association Studies
650	0	4	_aGlycine _xblood
650	0	4	_aGlycine Dehydrogenase (Decarboxylating) _xgenetics
650	0	4	_aHumans
650	0	4	_aIntrons _xgenetics
650	0	4	_aLinkage Disequilibrium
650	0	4	_aMale
650	0	4	_aMetabolome _xdrug effects
650	0	4	_aNuclear Proteins _xmetabolism
650	0	4	_aPolymorphism, Single Nucleotide
650	0	4	_aSelective Serotonin Reuptake Inhibitors _xtherapeutic use
700	1		_aHebbring, S
700	1		_aZhu, H
700	1		_aJenkins, G D
700	1		_aBiernacka, J
700	1		_aSnyder, K
700	1		_aDrews, M
700	1		_aFiehn, O
700	1		_aZeng, Z
700	1		_aSchaid, D
700	1		_aMrazek, D A
700	1		_aKaddurah-Daouk, R
700	1		_aWeinshilboum, R M
773	0		_tClinical pharmacology and therapeutics _gvol. 89 _gno. 1 _gp. 97-104
856	4	0	_uhttps://doi.org/10.1038/clpt.2010.250 _zAvailable from publisher's website
999			_c20400415 _d20400415